Nasdaq:US$15.97 (-0.33) | HKEX:HK$25.55 (+0.10) | AIM:£2.39 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice